Continue to expand the ngs field! Roche acquires Kapa biosystems

August 19, 2015 / BIOON / -- Roche, a Swiss pharmaceutical giant, recently announced an acquisition agreement with Kapa biosystems, a US based gene technology company Kapa biosystems is located in Wilmington, Massachusetts, USA It is a protein engineering expert and genomics tool supplier It is dedicated to the research, development and production of enzymes and related reagents for next generation sequencing (NGS) The products developed by Kapa biosystems based on the direct molecular evolution platform have been widely used in DNA amplification, sequencing, genomics research, molecular diagnosis and other fields The acquisition is in line with Roche's vision of further expansion in the next generation sequencing (NGS) field According to Roche, Kapa's proprietary direct molecular evolution platform is a highly customizable protein engineering technology, which can generate and screen a large number of enzyme mutants, customize high-performance biological enzymes for specific applications, and accelerate the development progress of related products The company's impressive combination of NGS reagents, including various enzymes, such as novel DNA polymerases, is expected to improve the performance of the entire sequencing workflow In fact, Roche and Kapa have been cooperating since 2013 At the end of last year, Kapa agreed to develop and produce customized RNA sequencing sample preparation kits for nimblegen unit of Roche Now Roche has decided to acquire Kapa and strengthen its next generation sequencing (NGS) product assets According to Roche, the acquisition of Kapa is based on Roche's strategy of developing a differentiated ngs product portfolio, aiming to provide its customers with a complete set of genetic testing solutions Kapa's technology and products are complementary to Roche's current expertise and products, which will enhance Roche's ngs product portfolio and contribute to Roche's expansion in the field of ngs Source: Roche to acquire Kapa biosystems to strengthen next generation sequencing product offerings